Cite
MLA Citation
A. A. Butt et al.. “Adding ribavirin to newer DAA regimens does not affect SVR rates in HCV genotype 1 infected persons: results from ERCHIVES.” Alimentary pharmacology & therapeutics, vol. 44, no. 7, 2016, pp. 728–737. http://access.bl.uk/ark:/81055/vdc_100035719291.0x000055